Search filters

List of works by Kenro Hirata

Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori.

scientific article published in May 2010

Development of a novel microRNA promoter microarray for ChIP-on-chip assay to identify epigenetically regulated microRNAs.

scientific article published on 11 August 2012

Efficacy of 10-day Sitafloxacin-Containing Third-Line Rescue Therapies for Helicobacter pylori Strains Containing the gyrA Mutation.

scientific article

Efficacy of sitafloxacin-based rescue therapy for Helicobacter pylori after failures of first- and second-line therapies.

scientific article published on 27 December 2011

Enhanced bacterial efflux system is the first step to the development of metronidazole resistance in Helicobacter pylori

scientific article published on 11 December 2010

Enhancement of Amoxicillin Resistance after Unsuccessful Helicobacter pylori Eradication

scientific article published in 2013

FecA1, a bacterial iron transporter, determines the survival of Helicobacter pylori in the stomach

scientific article published on 23 December 2011

Gastrointestinal: Ten‐millimeter advanced duodenal cancer with a gastric phenotype

scientific article published in 2022

Helicobacter pylori resistance to rifabutin in the last 7 years.

scientific article

Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study

scientific article

Soft palatal melanosis, a simple predictor for neoplasia in the upper aerodigestive tract in Japanese alcoholic men

scientific article

The tumor suppressor microRNA-29c is downregulated and restored by celecoxib in human gastric cancer cells.

scientific article

Two amino acids mutation of ferric uptake regulator determines Helicobacter pylori resistance to metronidazole

scientific article published on 26 August 2010

Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy-the P-SELECT trial (WJOG10617G)-a randomised phase

scientific article published on 12 June 2020